Epinephrine 0.3 MG auto-inject 2S
Ended Awarded Last action
- Contract number
- SPE2DR26FCY4T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,329
Award facts
- Contract value 100% obligated
- $12,328.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,328.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract, awarded on January 7, 2026, with an ultimate completion date of January 8, 2026, represents a non-set-aside procurement conducted through open competition. Performance will take place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under the parent company Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The epinephrine auto-injectors being procured under this delivery order are essential emergency medical supplies used across military treatment facilities and other federal healthcare institutions. This contract award reflects the company's continued capability to fulfill government requirements for specialized pharmaceutical commodities and medical devices through the DLA's established pharmaceutical supply chain, which also plans to implement new Pharmaceutical Prime Vendor Global Program Generation V contracts in the coming years to support diverse regional and service-specific requirements.
Quick answers
Who was awarded contract SPE2DR26FCY4T?
SPE2DR26FCY4T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FCY4T worth?
The government has obligated $12,329 on SPE2DR26FCY4T.
Is contract SPE2DR26FCY4T an order under another contract?
Yes. SPE2DR26FCY4T is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCY4T competed?
The extent of competition for SPE2DR26FCY4T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award